Trademark Overview
On Wednesday, September 3, 2025, a trademark application was filed for RESOLVE DX with the United States Patent and Trademark Office. The USPTO has given the RESOLVE DX trademark a serial number of 99372568. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Saturday, January 24, 2026. This trademark is owned by Harbinger Health, Inc.. The RESOLVE DX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical research services for measuring positive predictive value for cancer screening and for high resolution cancer screening and risk stratification;Software featuring machine learning and AI for analyzing positive predictive value for cancer;Software featuring machine learning and AI for high resolution cancer screening and risk stratification